Warren Eric (CIK 1916048) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-22). Recent activity: Sell MLYS (7,438 shares), Buy MLYS (7,438 shares), Buy MLYS (7,437 shares), Sell MLYS (7,437 shares), Sell MLYS (7,438 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-22 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Sell | 7,438 | $209,136 |
| 2026-09-22 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Buy | 7,438 | $98,479 |
| 2026-08-25 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Buy | 7,437 | $98,466 |
| 2026-08-25 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Sell | 7,437 | $193,189 |
| 2026-07-23 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Sell | 7,438 | $199,885 |
| 2026-07-23 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Buy | 7,438 | $98,479 |
| 2026-06-30 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Buy | 104,124 | $1.4M |
| 2026-06-30 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Sell | 104,124 | $2.7M |
| 2025-04-21 | Esperion Therapeutics, Inc. (ESPR) | Chief Commercial Officer | Sell | 108 | $106 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22